• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    A randomized, controlled trial of Shutangluo fang in treating painful diabetic peripheral neuropathy

    2016-03-27 07:41:46DiHongjie狄紅杰ChuXiaoqiu褚曉秋LiuKemian劉克冕andLiuChao劉超
    關(guān)鍵詞:劉超

    Di Hongjie(狄紅杰), Chu Xiaoqiu(褚曉秋), Liu Kemian(劉克冕), and Liu Chao(劉超)

    Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210028, China

    A randomized, controlled trial of Shutangluo fang in treating painful diabetic peripheral neuropathy

    Di Hongjie(狄紅杰), Chu Xiaoqiu(褚曉秋), Liu Kemian(劉克冕), and Liu Chao(劉超)*

    Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210028, China

    OBJECTIVE:To assess efficacy of Shutangluo fang on painful diabetic peripheral neuropathy(PDPN).

    Painful diabetic peripheral neuropathy; Shutangluo fang; Epalrestat

    Painful diabetic peripheral neuropathy (PDPN) is one of the common chronic complications of diabetes,which are often associated with considerable morbidity and mortality. It requires medical attention because of its adverse effects on quality of life1. There are many treatment options available include anticonvulsants, antidepressants, opioids and others2. But there are problems of side-effects and contraindications for all these drugs3. Thus, the development of new drugs to manage PDPN remains a high priority.

    Shutangluo fang, which has been long used as an anti-diabetes medicine in our department, proved to be effective on diabetic peripheral neuropathy (DPN). This study evaluated the efficacy of Shutangluo fang in relieving PDPN.

    METHODS

    Overview

    This was a randomized, placebo-controlled, parallel-group study. Eighty-two patients with PDPN were invited to participate in this clinical trial starting from July 2013 to May 2016 at endocrine and diabetes center of Jiangsu Province Hospital on Integration of Chinese and Western Medicine. The patients were composed of 46 men and 34 women, with the mean age of 56.54±7.82 years. Each patient read and signed informed consent before initiating any study procedures.

    Selection criteria

    All the patients enrolled in the study should meet the diagnostic criteria for PDNP issued by Chinese Diabetes Society (CDS)4. The criteria mainly include:① Diabetes for at least 3 months on stable dosage of oral hypoglycemic agent or insulin.②Daily neuropathic pain of at least moderate severity for more than 3 months.③Written consent to participate in the study.

    Exclusion criteria

    Patients with hemoglobin A1c levels of more than 11% were excluded, as were patients with clinically significant or unstable liver, hematologic, or respiratory illnesses, vitamin def i ciency, symptomatic peripheral vascular disease, or unstable cardiovascular disease.

    Study design

    All patients were divided into the control group (CG) and Shutangluo fang treatment group (STG) randomly. Both groups recieved conventional therapy (diet treatment, hypoglycemic agents, insulin, and hypotensive agents) and held constant throughout the study. Adequate glucose control was maintained to ensure patient safety. Epalrestat (50 mg) was orally administered three times daily before each meal (150 mg/day) for each patient. The patients in treatment group received Shutangluo fang, which composed of euonymus alatus, trumpetcreeper, rehmannia,rhizoma coptidis and radix puerariae lobatae. The course of treatment lasts for 3 months.

    Laboratory studies

    All patients were subjected to thorough interview, clinical examination and relevant laboratory investigations. All of them were asked to fill in (by themselves or with assistance) visual analogue score (VAS) first initially, then after 3 months. Biochemical examinations, which included fasting blood glucose (FBG), HbA1c, lipid prof i le was done at the beginning of the study and after 3 months. Electrophysiological studies, in the form of sensory nerve conduction studies (SNCV), were performed at the beginning of the study and after 3 months in both groups.

    Efficacy measures

    The primary efficacy measure for this study was the reduction in mean of the 24-hour average pain scores (computed from diary scores between two site visits), as measured by an 11-point (0 = no pain, 10 = worst possible pain) Likert scale that was completed daily by the patients in a diary. We considered a reduction difference more than 30% a significant effect, from 15% to 30% in an insignif i cant ef f ect, and less than 15% in no ef f ect5.

    Statistical analysis

    All statistical testing were two-sided and performed using SAS procedures. All values (e.g. HbA1c) were expressed as means ± SD. Statistical methods used includedx2tests for nominal scale, two-sample tests for comparison of mean values between groups. Values were adjusted using the Hochberg25 procedure in order to protect the type I error rate at the 0.05 level.

    RESULTS

    Patient disposition, demographics, and disease characteristics

    A total of 82 patients were randomized to the study. The demographics for all patients, 41 patients were treated with epalrestat (CG) and 41 patients were treated with Shutangluo fang with epalrestat (STG), are provided in Table 1. There were no signif i cant dif f erences between two groups.

    Table 1. Selected characteristics of subjects

    Changes in glycemic control and lipid prof i le

    Changes in glycemic control and lipid profile of the patients were followed up for 3 months. In the control group (n= 41), A1C (means ± SD) at baseline and 3 months was (7.71±1.05), and (7.91±1.02)%, respectively. Corresponding values in the Shutangluo fang group (n=41) were (7.82 ± 1.12), and (7.79±1.11)%, respectively. There were no signif i cant dif f erences between the two groups. Also, there were no significant differences in lipid profile between the two groups at any time points (Table 2).

    Table 2. Mean change from baseline to endpoint of HbA1c and lipid pro fi le

    Table 2. Mean change from baseline to endpoint of HbA1c and lipid pro fi le

    FBG: fasting blood glucose; LDL-C: low density lipoprotein cholesterol.HbA1C: glycosylated hemoglobin A1C; TG: total triglyceride;*P>0.05, versus baseline;▲P>0.05,versus control group.

    Parameter Control group Treatment group Baseline EndpointBaseline Endpoint Number(n)4141 FBG(mmol/L)8.58±1.838.49±1.93*8.61±1.928.48±1.95*▲HbA1C(%)7.71±1.057.91±1.02*7.82±1.127.79±1.11*▲LDL-C(mmol/L)2.86±1.192.79±1.12*2.91±1.212.88±0.99*▲TG(mmol/L)1.81±0.811.79±0.88*1.79±0.851.78±0.89*▲

    Change in subjective symptoms

    At baseline, the pain scores based on visual analogue score (VAS) had no significant difference between the two groups (5.73±1.17 VS 5.68±1.19, P>0.05). At the endpoint, both groups signif i cantly reduced pain compared to the baseline. The endpoint mean pain score, was signif i cantly improved by Shutangluo fang when compared to the control group (2.21±0.82 VS 4.13±0.97,P<0.05).

    The proportion of patients achieving a >15% reduction in pain was signif i cantly higher in Shutangluo fang group than the control group (Table 3).

    Table 3. Analysis of the proportion of responders

    Change in sensory nerve conduction velocity(SNCV)

    Table 4 shows each electrophysiological measure (means ± SD) at the baseline and end-of-treatment time points. At baseline, no statistically signif i cant deteriorations in median SNCV were observed in the two groups. The electrophysiological measure of sensory function measures demonstrated signif i cant improvement (P<0.05) over the 3-month treatment period in both groups. At the endpoint, mean SNCV was significantly improved by Shutangluo fang when compared to the control group (P<0.05).

    Table 4. Analysis of the nerve conduction velocity

    Table 4. Analysis of the nerve conduction velocity

    *P<0.05, versus baseline;▲P<0.05, versus control group.

    Median nerveUlnar nerveCommon peroneal nerveTibial nervenBaselineEndpointBaselineEndpointBaselineEndpointBaselineEndpoint Treatment group4135.43±3.55 45.79±4.15*▲34.83±4.02 46.19±3.97*▲33.89±3.85 46.08±4.27*▲34.51±3.95 47.69±4.28*▲Control group4135.75±3.6240.16±4.01*35.02±3.9839.99±3.99*34.09±4.0639.06±4.38*34.28±3.8940.56±4.35*

    DISCUSSION

    Painful diabetic peripheral neuropathy represents a diffuse symmetric and length-dependent injury to patients and it has bad ef f ect on quality of life, morbidity, and costs from a public health perspective6. Although several pivotal trials have shown that strict glycemic control reduces the occurrence and progression of diabetes-related complications, it is difficult to restore nerve function7. So far no ideal drug has been available for its management. In this trial, Shutangluo fang was effective on PDPN.

    As we all know, hyperglycemia-induced hyperactivity of polyol pathway links to the augmentation of the metabolic disorders, like oxidative stress, and others, contributing to the deterioration of diabetic neuropathy. Suppression of this pathway may be an important key to efficient treatment for DPDN. The key enzyme of the polyol pathway is aldose reductase (AR). There are many reports supporting the beneficial effects of AR inhibitors in animal models for diabetic neuropathy and diabetic patients8. In our clinical trial, epalrestat which is the only ARI currently available commercially, is ef f ective on PDPN. But we also fi nd its ef f ect for symptoms (e.g. pain) is poor in clinical practice.

    There is no painful diabetic peripheral neuropathy in terms of traditional Chinese medicine (TCM). However, according to its clinical manifestations, the disease may belong to the categories ofarthralgia zheng. Its etiology and pathogenesis mainly lie in uncontrolled diet or interior injury by seven emotions, which result in extreme heat with yin asthenia and stagnation of blood, failure of the transport nutrients to extremities, ultimately led to the symptoms including pain.

    Many studies have demonstrated the efficacy of Chinese medicine in painful diabetic peripheral neuropathy9. Shutangluo fang is the clinical experienced prescription of our department. Euonymus alatus is the principal drug of Shutangluo fang. Its effects include disintegrating blood stasis and dredging collaterals, eliminating stasis to activate blood circulation and relieve pain. The ministerial drug is trumpetcreeper which is added to strengthen the effects of promoting blood circulationand remove blood stasis. Rehmannia, rhizoma coptidis and radix puerariae lobatae are used to clear away heat, nourishing Yin and cooling blood. The results presented here indicate that Shutangluo fang can relieve the pain and improve the sensory nerve conduction velocity.

    In conclusion, Shutangluo fang is ef f ective on painful diabetic peripheral neuropathy. But we need long-term clinic trial to assess the efficacy and safety of Shutangluo fang in the treatment of painful diabetic neuropathy.

    REFERENCES

    1 Argof f CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc,2006(81): S3-S11.

    2 Casandra JR, James CW. Treatment of painful diabetic peripheral neuropathy. Prosthet Orthot Int,2015,39(1):17-28.

    3 Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med,2000(108):2-8.

    4 Chinese Diabetes Society. Guidelines for prevention and treatment of type 2 diabetes in China. Chin J Endocrinol Metab,2014,30(10):893-942.

    5 Wernicke JF, Pritchett YL, D’Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology, 2006,67(8):1411-1420.

    6 Sadosky A, Schaefer C, Mann R, et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes,2013(6):79-92.

    7 Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev,2014(2):CD009122.

    8 Li Ping, Ma Jianhua, Gao Jialin, et al. Clinical efficacy and safety of epalrestat in diabetic neuropathy-A multicenter randomized controlled clinical trial. Chin J Endocrinol Metab,2015,31(9):743-747.

    9 Pang GM, Zhu P, Han JT, et al. Clinical research on treatment of 60 patients with Diabetic peripheral neuropathy by Jiangtang Tongluo tablets. Clinical Journal of Chinese Medicine,2014,6(30):3-6.

    (Accepted: June 29, 2016)

    *Corresponding author: E-mail:liuchao@hotmail.com;Mobile phone:+86-258-5608735

    METHODS:Adopting stratified randomized and controlled design,82 patients with PDPN were assigned to two groups. Both groups continued conventional therapy. Epalrestat was administered to patients in both groups,and Shutangluo fang was given to patients in the treatment group.The treatment course lasted for 3 months. The changes before and after treatment of symptoms and signs, electrophysiological assessments were observed.

    RESULTS:The efficacy of the treatment group was better than the control group. The sensory nerve conduction velocity was significantly improved in the treatment group than the control group.

    CONCLUSIONS:Shutangluo fang is ef f ective on PDPN.

    猜你喜歡
    劉超
    老吳的拉面館
    Theoretical study of novel B-C-O compounds with non-diamond isoelectronic
    Removal of GaN film over AlGaN with inductively coupled BCl3/Ar atomic layer etch
    征程萬里,初心如一
    雷鋒(2021年12期)2021-04-12 00:57:22
    《站立式起跑》教學(xué)設(shè)計(jì)
    小數(shù)與小數(shù)點(diǎn)
    小數(shù)與小數(shù)點(diǎn)
    Design and experiment of the centrifugal pump impellers with twisted inlet vice blades *
    A simple method for estimating bed shear stress in smooth and vegetated compound channels*
    Support Effects on Thiophene Hydrodesulfurization over Co-Mo-Ni/Al2O3and Co-Mo-Ni/TiO2-Al2O3Catalysts*
    少妇人妻 视频| 久久精品人人爽人人爽视色| 免费少妇av软件| 亚洲少妇的诱惑av| 亚洲av综合色区一区| 晚上一个人看的免费电影| 国产精品一二三区在线看| 九色亚洲精品在线播放| 精品久久久精品久久久| 亚洲欧美日韩卡通动漫| 久久国产亚洲av麻豆专区| 少妇的逼好多水| 久久99蜜桃精品久久| 岛国毛片在线播放| 日韩在线高清观看一区二区三区| 成人无遮挡网站| 国产成人免费无遮挡视频| 亚洲内射少妇av| 免费播放大片免费观看视频在线观看| 高清黄色对白视频在线免费看| 国产成人午夜福利电影在线观看| 日本欧美国产在线视频| 一级a做视频免费观看| 欧美人与性动交α欧美精品济南到 | 欧美最新免费一区二区三区| 国产精品久久久av美女十八| 亚洲欧美色中文字幕在线| 男人舔女人的私密视频| 久热久热在线精品观看| 午夜激情av网站| 久久久精品区二区三区| 亚洲高清免费不卡视频| 午夜免费鲁丝| 亚洲色图综合在线观看| 高清不卡的av网站| 一区二区三区乱码不卡18| 国产免费一区二区三区四区乱码| 免费在线观看黄色视频的| 久久精品久久久久久噜噜老黄| 国产成人精品在线电影| 男人添女人高潮全过程视频| 久久99热6这里只有精品| 大香蕉97超碰在线| 亚洲国产精品成人久久小说| 亚洲欧美日韩另类电影网站| 久久久精品区二区三区| 99久久精品国产国产毛片| 夜夜骑夜夜射夜夜干| 色婷婷久久久亚洲欧美| 国产 精品1| 中文乱码字字幕精品一区二区三区| 丰满少妇做爰视频| av国产久精品久网站免费入址| 日本爱情动作片www.在线观看| 伦理电影免费视频| 欧美日韩视频高清一区二区三区二| 成人18禁高潮啪啪吃奶动态图| 我的女老师完整版在线观看| 亚洲av男天堂| www.色视频.com| 亚洲av男天堂| 久久av网站| 亚洲精品国产av蜜桃| 日韩欧美精品免费久久| 亚洲天堂av无毛| 深夜精品福利| 欧美3d第一页| 高清不卡的av网站| 桃花免费在线播放| 国产成人91sexporn| 欧美亚洲 丝袜 人妻 在线| 久久久亚洲精品成人影院| 国产黄频视频在线观看| 国产一区二区三区av在线| 男人操女人黄网站| 日韩伦理黄色片| 色婷婷av一区二区三区视频| 视频区图区小说| 精品久久久久久电影网| 久久精品久久久久久噜噜老黄| 香蕉丝袜av| 伊人久久国产一区二区| 99热6这里只有精品| 日日摸夜夜添夜夜爱| 男女边吃奶边做爰视频| 国产成人免费观看mmmm| 日本午夜av视频| 天天躁夜夜躁狠狠久久av| 国产av码专区亚洲av| 五月开心婷婷网| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | av福利片在线| 波多野结衣一区麻豆| 午夜日本视频在线| 午夜福利网站1000一区二区三区| 人人妻人人爽人人添夜夜欢视频| 精品亚洲成国产av| 人妻系列 视频| 国内精品宾馆在线| 看免费av毛片| 久久久久久久精品精品| 中文精品一卡2卡3卡4更新| a级毛片在线看网站| 国产av码专区亚洲av| 欧美+日韩+精品| 成人亚洲精品一区在线观看| 寂寞人妻少妇视频99o| 精品熟女少妇av免费看| 日韩人妻精品一区2区三区| 日韩中字成人| 日韩av免费高清视频| 成人漫画全彩无遮挡| 久久热在线av| 91精品伊人久久大香线蕉| 久久影院123| 免费av中文字幕在线| 欧美另类一区| 中文字幕av电影在线播放| 亚洲国产精品成人久久小说| 久久精品夜色国产| 久久精品国产综合久久久 | 热99国产精品久久久久久7| 亚洲av男天堂| 亚洲美女视频黄频| 一级,二级,三级黄色视频| 亚洲成人av在线免费| 高清视频免费观看一区二区| 久久精品aⅴ一区二区三区四区 | 亚洲国产精品一区三区| 国产欧美另类精品又又久久亚洲欧美| 国产精品国产三级专区第一集| 夫妻性生交免费视频一级片| 老司机影院毛片| 亚洲久久久国产精品| 日韩在线高清观看一区二区三区| 亚洲少妇的诱惑av| 在线亚洲精品国产二区图片欧美| 下体分泌物呈黄色| 精品久久久精品久久久| 国产精品久久久久久av不卡| 久久ye,这里只有精品| 黄色怎么调成土黄色| 在线观看国产h片| 亚洲欧洲精品一区二区精品久久久 | 欧美日韩一区二区视频在线观看视频在线| 国产成人午夜福利电影在线观看| 自线自在国产av| 久久99热6这里只有精品| 久久国内精品自在自线图片| 久久午夜福利片| 久久韩国三级中文字幕| av在线播放精品| 丰满迷人的少妇在线观看| 久久综合国产亚洲精品| 国产男女内射视频| 国产男人的电影天堂91| 桃花免费在线播放| 亚洲伊人久久精品综合| 美女国产视频在线观看| 少妇人妻 视频| 观看av在线不卡| 国产精品无大码| 男女啪啪激烈高潮av片| 午夜日本视频在线| 永久免费av网站大全| 国产av精品麻豆| 日韩熟女老妇一区二区性免费视频| 亚洲三级黄色毛片| 伊人久久国产一区二区| 成年av动漫网址| 晚上一个人看的免费电影| 亚洲精品成人av观看孕妇| 欧美国产精品va在线观看不卡| 国产成人av激情在线播放| 国产精品欧美亚洲77777| 一级片'在线观看视频| av片东京热男人的天堂| 国产国语露脸激情在线看| 波多野结衣一区麻豆| 一区在线观看完整版| 亚洲色图 男人天堂 中文字幕 | 寂寞人妻少妇视频99o| 日韩熟女老妇一区二区性免费视频| 一区二区日韩欧美中文字幕 | 免费人成在线观看视频色| 成人综合一区亚洲| 精品亚洲成国产av| av在线app专区| 丝瓜视频免费看黄片| 午夜福利视频在线观看免费| 亚洲美女搞黄在线观看| 久久久久久人妻| 在线亚洲精品国产二区图片欧美| 久久精品夜色国产| 三级国产精品片| 少妇熟女欧美另类| 水蜜桃什么品种好| 亚洲欧美一区二区三区国产| 97人妻天天添夜夜摸| 韩国高清视频一区二区三区| 成人二区视频| 性色av一级| 建设人人有责人人尽责人人享有的| 美女内射精品一级片tv| 亚洲伊人久久精品综合| 国产熟女午夜一区二区三区| 亚洲熟女精品中文字幕| 亚洲精品美女久久av网站| 国产xxxxx性猛交| 啦啦啦啦在线视频资源| 超碰97精品在线观看| 中文字幕制服av| 黄片播放在线免费| 好男人视频免费观看在线| 亚洲少妇的诱惑av| 大陆偷拍与自拍| 五月伊人婷婷丁香| 日韩精品有码人妻一区| 欧美国产精品一级二级三级| 黑人猛操日本美女一级片| 亚洲成人手机| 三级国产精品片| 久久久精品区二区三区| 女人被躁到高潮嗷嗷叫费观| 内地一区二区视频在线| 国产成人精品一,二区| 秋霞伦理黄片| 免费在线观看完整版高清| 99re6热这里在线精品视频| 日韩成人伦理影院| 国产免费福利视频在线观看| 国产永久视频网站| 在线观看免费日韩欧美大片| 欧美bdsm另类| 日韩大片免费观看网站| 国产激情久久老熟女| 日本爱情动作片www.在线观看| 狠狠精品人妻久久久久久综合| 欧美成人午夜免费资源| 十八禁高潮呻吟视频| 亚洲国产看品久久| 亚洲精品一二三| 国产在线视频一区二区| 中文字幕人妻丝袜制服| 视频在线观看一区二区三区| 美女主播在线视频| 桃花免费在线播放| 少妇的逼好多水| 国产亚洲最大av| 欧美人与性动交α欧美软件 | 精品一品国产午夜福利视频| 中国美白少妇内射xxxbb| 九草在线视频观看| 国产成人精品无人区| 亚洲精品,欧美精品| 久久久久精品久久久久真实原创| 一区在线观看完整版| 色吧在线观看| 国国产精品蜜臀av免费| 啦啦啦中文免费视频观看日本| 久久国产亚洲av麻豆专区| 在线 av 中文字幕| 久久99热6这里只有精品| 久久久久久人妻| 人妻 亚洲 视频| 五月开心婷婷网| 国产女主播在线喷水免费视频网站| 满18在线观看网站| 国产精品一国产av| 99热网站在线观看| 狂野欧美激情性xxxx在线观看| 久久综合国产亚洲精品| 亚洲综合精品二区| 热re99久久精品国产66热6| 乱码一卡2卡4卡精品| 日本黄色日本黄色录像| 亚洲第一区二区三区不卡| 亚洲精品日韩在线中文字幕| 超色免费av| 亚洲成国产人片在线观看| 青青草视频在线视频观看| 午夜福利影视在线免费观看| 热re99久久精品国产66热6| 国产色爽女视频免费观看| 亚洲性久久影院| 亚洲欧美一区二区三区黑人 | 人体艺术视频欧美日本| 婷婷色麻豆天堂久久| 人人妻人人澡人人看| 免费久久久久久久精品成人欧美视频 | 成人黄色视频免费在线看| 爱豆传媒免费全集在线观看| 精品第一国产精品| 高清欧美精品videossex| 高清毛片免费看| 热99久久久久精品小说推荐| 欧美日韩综合久久久久久| 日韩av在线免费看完整版不卡| 成人黄色视频免费在线看| 国产亚洲欧美精品永久| 卡戴珊不雅视频在线播放| 国产精品99久久99久久久不卡 | 亚洲精品视频女| 日韩中文字幕视频在线看片| 亚洲精品av麻豆狂野| 丝袜脚勾引网站| 在线观看www视频免费| 在线观看www视频免费| 久久人人97超碰香蕉20202| 人妻 亚洲 视频| 午夜福利,免费看| 看免费成人av毛片| 熟女电影av网| 精品国产露脸久久av麻豆| 亚洲一区二区三区欧美精品| 少妇猛男粗大的猛烈进出视频| 亚洲国产精品专区欧美| 综合色丁香网| 97人妻天天添夜夜摸| 极品少妇高潮喷水抽搐| 国产免费现黄频在线看| 亚洲国产av影院在线观看| 久久久久人妻精品一区果冻| 亚洲综合精品二区| 如何舔出高潮| 国产精品不卡视频一区二区| 国产免费福利视频在线观看| 日韩精品有码人妻一区| 欧美性感艳星| 男人爽女人下面视频在线观看| 蜜桃国产av成人99| 亚洲在久久综合| 一级,二级,三级黄色视频| 五月玫瑰六月丁香| 亚洲婷婷狠狠爱综合网| 亚洲五月色婷婷综合| 久久狼人影院| 99视频精品全部免费 在线| 午夜av观看不卡| 激情五月婷婷亚洲| 99久国产av精品国产电影| 午夜精品国产一区二区电影| 国产av一区二区精品久久| 欧美日韩一区二区视频在线观看视频在线| 中文欧美无线码| 成人影院久久| 下体分泌物呈黄色| 国产免费又黄又爽又色| 肉色欧美久久久久久久蜜桃| 国产极品粉嫩免费观看在线| 亚洲,一卡二卡三卡| 国产精品国产三级国产专区5o| 高清在线视频一区二区三区| 亚洲精品美女久久av网站| 久久99精品国语久久久| 久久久国产一区二区| 国产精品久久久久久精品电影小说| 晚上一个人看的免费电影| 午夜免费男女啪啪视频观看| 日本黄大片高清| 国产成人免费观看mmmm| 久久 成人 亚洲| 18禁观看日本| 免费大片黄手机在线观看| 在线观看免费日韩欧美大片| av一本久久久久| 久久久久精品性色| 国产日韩欧美在线精品| 大陆偷拍与自拍| 大片电影免费在线观看免费| 春色校园在线视频观看| 亚洲少妇的诱惑av| 黑丝袜美女国产一区| 日韩不卡一区二区三区视频在线| 国产国拍精品亚洲av在线观看| 国产免费一区二区三区四区乱码| 久久久久国产精品人妻一区二区| 韩国精品一区二区三区 | 亚洲美女视频黄频| 天堂8中文在线网| 日韩一区二区三区影片| 97超碰精品成人国产| 亚洲激情五月婷婷啪啪| 久久久精品94久久精品| 国产成人aa在线观看| 秋霞伦理黄片| 男女边摸边吃奶| 精品少妇久久久久久888优播| 亚洲精品日本国产第一区| 精品国产一区二区三区四区第35| 黄色一级大片看看| 哪个播放器可以免费观看大片| 亚洲综合色网址| 中文乱码字字幕精品一区二区三区| 女人被躁到高潮嗷嗷叫费观| www.av在线官网国产| 日本与韩国留学比较| 9色porny在线观看| 水蜜桃什么品种好| 国产高清三级在线| 亚洲一码二码三码区别大吗| 各种免费的搞黄视频| 色婷婷久久久亚洲欧美| 国产色婷婷99| 大话2 男鬼变身卡| 欧美另类一区| a级毛色黄片| 黄色一级大片看看| 欧美bdsm另类| 咕卡用的链子| 巨乳人妻的诱惑在线观看| 国产成人精品无人区| 国产亚洲欧美精品永久| 97人妻天天添夜夜摸| a级片在线免费高清观看视频| 亚洲第一区二区三区不卡| 黑人高潮一二区| 黄色视频在线播放观看不卡| 少妇的逼水好多| 国产黄频视频在线观看| 久久精品久久精品一区二区三区| 麻豆精品久久久久久蜜桃| 亚洲,欧美,日韩| 最黄视频免费看| 王馨瑶露胸无遮挡在线观看| 日本91视频免费播放| 日本免费在线观看一区| 精品一区二区三区四区五区乱码 | 久久这里有精品视频免费| 1024视频免费在线观看| 一级毛片 在线播放| 国精品久久久久久国模美| 中文字幕制服av| 久久精品熟女亚洲av麻豆精品| 国产一区二区激情短视频 | 妹子高潮喷水视频| 精品酒店卫生间| 女人精品久久久久毛片| 最近手机中文字幕大全| 巨乳人妻的诱惑在线观看| 亚洲精品乱码久久久久久按摩| 丰满迷人的少妇在线观看| 国产精品久久久久久精品古装| 午夜影院在线不卡| 亚洲av中文av极速乱| 视频中文字幕在线观看| 免费黄网站久久成人精品| 精品国产露脸久久av麻豆| 久久久国产一区二区| 日韩一区二区三区影片| 国产成人精品在线电影| 亚洲成国产人片在线观看| 51国产日韩欧美| 久久久久久久久久成人| 日本vs欧美在线观看视频| 热99国产精品久久久久久7| 在线观看美女被高潮喷水网站| 久久久久视频综合| 一级黄片播放器| 久久精品人人爽人人爽视色| 美女国产视频在线观看| 下体分泌物呈黄色| 久久久久精品人妻al黑| 女人精品久久久久毛片| 国产精品国产三级国产专区5o| 精品人妻在线不人妻| 99香蕉大伊视频| 中文乱码字字幕精品一区二区三区| 久久狼人影院| 大香蕉久久成人网| 精品久久久精品久久久| 另类亚洲欧美激情| 极品人妻少妇av视频| 国产精品一区www在线观看| 亚洲在久久综合| 亚洲国产欧美在线一区| 丝袜在线中文字幕| 亚洲欧美精品自产自拍| 视频中文字幕在线观看| 精品亚洲成国产av| 这个男人来自地球电影免费观看 | 韩国精品一区二区三区 | 久久综合国产亚洲精品| 亚洲少妇的诱惑av| 汤姆久久久久久久影院中文字幕| 国产综合精华液| 国产精品麻豆人妻色哟哟久久| 国产成人精品无人区| av在线播放精品| 又黄又爽又刺激的免费视频.| 伊人亚洲综合成人网| 免费观看无遮挡的男女| 国产又爽黄色视频| 99香蕉大伊视频| 一二三四在线观看免费中文在 | 日韩av不卡免费在线播放| av国产久精品久网站免费入址| 日本欧美视频一区| 成人黄色视频免费在线看| videossex国产| 欧美激情 高清一区二区三区| 久久99蜜桃精品久久| 国产精品嫩草影院av在线观看| 午夜福利乱码中文字幕| 亚洲国产av影院在线观看| 久久精品久久久久久久性| 制服丝袜香蕉在线| 日日摸夜夜添夜夜爱| 两个人免费观看高清视频| 少妇人妻久久综合中文| 国产69精品久久久久777片| 久久99一区二区三区| 91精品伊人久久大香线蕉| 国产av一区二区精品久久| www.色视频.com| 国产精品一二三区在线看| 国产免费福利视频在线观看| 久久青草综合色| 80岁老熟妇乱子伦牲交| 少妇人妻 视频| 性色av一级| 成人毛片a级毛片在线播放| 欧美国产精品va在线观看不卡| 午夜福利,免费看| 五月伊人婷婷丁香| 麻豆精品久久久久久蜜桃| 在线天堂最新版资源| 综合色丁香网| 亚洲精品美女久久av网站| 综合色丁香网| 久久久久国产网址| 热re99久久国产66热| 国产高清不卡午夜福利| 欧美人与性动交α欧美软件 | 在线观看国产h片| 精品一品国产午夜福利视频| 又粗又硬又长又爽又黄的视频| 亚洲精品日本国产第一区| 精品国产露脸久久av麻豆| 精品国产国语对白av| 国产白丝娇喘喷水9色精品| 国产av国产精品国产| 免费看光身美女| 天堂8中文在线网| 人人妻人人爽人人添夜夜欢视频| 一级片'在线观看视频| 日本91视频免费播放| 国产一区二区在线观看av| 久久久久久久大尺度免费视频| 高清黄色对白视频在线免费看| 成人无遮挡网站| 欧美日本中文国产一区发布| 成人影院久久| 男女午夜视频在线观看 | 人人妻人人澡人人看| 久久久精品区二区三区| 亚洲一码二码三码区别大吗| 免费观看无遮挡的男女| 国产乱人偷精品视频| 日韩一本色道免费dvd| av国产久精品久网站免费入址| 丝袜在线中文字幕| 国产女主播在线喷水免费视频网站| 青青草视频在线视频观看| 寂寞人妻少妇视频99o| 9色porny在线观看| 欧美日本中文国产一区发布| 久久综合国产亚洲精品| 高清视频免费观看一区二区| 搡老乐熟女国产| 久久毛片免费看一区二区三区| 亚洲精品乱久久久久久| 涩涩av久久男人的天堂| 18禁裸乳无遮挡动漫免费视频| 丝瓜视频免费看黄片| 美女主播在线视频| 丝瓜视频免费看黄片| 十分钟在线观看高清视频www| 久久久久久久大尺度免费视频| 黄片无遮挡物在线观看| 久久青草综合色| 国产精品.久久久| 日韩欧美精品免费久久| 欧美xxⅹ黑人| 欧美日韩av久久| av在线观看视频网站免费| 久久精品久久久久久久性| 成人手机av| 999精品在线视频| 哪个播放器可以免费观看大片| 成年人午夜在线观看视频| 免费女性裸体啪啪无遮挡网站| 久久韩国三级中文字幕| 日韩熟女老妇一区二区性免费视频| 免费av中文字幕在线| 国产日韩欧美亚洲二区| 久久精品国产自在天天线| 婷婷成人精品国产| 美女主播在线视频| 一级黄片播放器| 蜜臀久久99精品久久宅男| 建设人人有责人人尽责人人享有的| 国产av码专区亚洲av| 日韩精品有码人妻一区| 最近的中文字幕免费完整| 亚洲一码二码三码区别大吗| 9热在线视频观看99| 美女大奶头黄色视频| 大香蕉97超碰在线| 国产女主播在线喷水免费视频网站| 久久97久久精品| 国产成人精品在线电影| 免费观看性生交大片5| 国产白丝娇喘喷水9色精品| 好男人视频免费观看在线|